Trial of Best Supportive Care and Either Cisplatin or Paclitaxel to Treat Patients With Primary Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer and Inoperable Malignant Bowel Obstruction

NCT01083537 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Slow accrual

Conditions

Ovarian Cancer
Peritoneal Cancer
Fallopian Tube Cancer
Bowel Obstruction

Interventions

DRUG: Cisplatin
DRUG: Paclitaxel

Sponsor

University Health Network, Toronto